Search Results - "Sha, Jiu‐Kai"

Preclinical characterization of danatinib as a novel FLT3 inhibitor with excellent efficacy against resistant acute myeloid leukemia by Sun, Shan-Liang, Wu, Jia-Zhen, Wang, Jing-Jing, Zhou, Hai, Zhang, Chen-Qian, Tong, Zhen-Jiang, Wang, Yi-Bo, Sha, Jiu-Kai, Wang, Qing-Xin, Liu, Jia-Chuan, Zheng, Xin-Rui, Li, Qing-Qing, Zhang, Meng-Yuan, Yang, Jin, Wei, Tian-Hua, Wang, Zi-Xuan, Yu, Yan-Cheng, Ding, Ning, Leng, Xue-Jiao, Xue, Xin, Li, He-Min, Dai, Wei-Chen, Yin, Xiao-Ying, Yang, Ye, Duan, Jin-Ao, Li, Nian-Guang, Shi, Zhi-Hao

“…The therapeutic benefits of available FLT3 inhibitors for AML are limited by drug resistance, which is related to mutations, as well toxicity caused by…”
Get full text

Discovery of 4‐(4‐aminophenyl)‐6‐phenylisoxazolo[3,4‐b]pyridine‐3‐amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemia by Wang, Qing‐Xin, Wang, Yi‐Bo, Sha, Jiu‐Kai, Zhou, Hai, Liu, Jia‐Chuan, Wu, Jia‐Zhen, Tong, Zhen‐Jiang, Cai, Jiao, Chen, Zi‐Jun, Zhang, Chen‐Qian, Zheng, Xin‐Rui, Wang, Jing‐Jing, Wang, Xiao‐Long, Xue, Xin, Yu, Yan‐Cheng, Ding, Ning, Leng, Xue‐Jiao, Dai, Wei‐Chen, Sun, Shan‐Liang, Chang, Liang, Li, Nian‐Guang, Shi, Zhi‐Hao

“…Small molecule covalent drugs have proved to be desirable therapies especially on drug resistance related to point mutations. Secondary mutations of FLT3 have…”
Get full text

Design and synthesis 1H-Pyrrolo[2,3-b]pyridine derivatives as FLT3 inhibitors for the treatment of Acute myeloid Leukemia by Wei, Tian-Hua, Zhou, Yun, Yang, Jin, Zhang, Meng-Yuan, Wang, Jing-Jing, Tong, Zhen-Jiang, Wu, Jia-Zhen, Wang, Yi-Bo, Sha, Jiu-Kai, Chen, Min, Ding, Ning, Yu, Yan-Cheng, Dai, Wei-Chen, Leng, Xue-Jiao, Xue, Xin, Sun, Shan-Liang, Wang, Xiao-Long, Li, Nian-Guang, Shi, Zhi-Hao

“…[Display omitted] Acute myeloid leukemia (AML) is the most common type of blood cancer and has been strongly correlated with the overexpression of Fms-like…”
Get full text

Discovery of 4‐(4‐aminophenyl)‐6‐phenylisoxazolopyridine‐3‐amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemia by Qing‐Xin Wang, Yi‐Bo Wang, Jiu‐Kai Sha, Zhou, Hai, Jia‐Chuan Liu, Jia‐Zhen Wu, Zhen‐Jiang Tong, Jiao Cai, Zi‐Jun Chen, Chen‐Qian Zhang, Xin‐Rui Zheng, Jing‐Jing Wang, Xiao‐Long Wang, Xue, Xin, Yan‐Cheng Yu, Ding, Ning, Xue‐Jiao Leng, Wei‐Chen Dai, Shan‐Liang Sun, Chang, Liang, Nian‐Guang Li, Zhi‐Hao Shi

“…Small molecule covalent drugs have proved to be desirable therapies especially on drug resistance related to point mutations. Secondary mutations of FLT3 have…”
Get full text